Forbes July 15, 2024
Robert Hart

Topline

Weight loss and diabetes may just be the beginning for drugs like Ozempic, Wegovy, Mounjaro and Zepbound as reports increasingly suggest they may have far-reaching benefits for treating conditions as diverse as heart disease, liver disease, Parkinson’s, sleep apnea and addiction, sparking research among firms competing in pharma’s latest gold rush.

Key Facts

Have Weight Loss Injections Been Linked To Any New Side Effects?

While the clinical trials required to bring a drug to market are extensive, rigorous and ensure products are safe and effective, they rarely provide a complete picture of a medication. The sheer number of people who take a drug after approval, especially popular ones like semaglutide and tirzepatide, can dwarf the number of people involved...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Share This Article